Low cholesterol levels are good markers for central hypothyroidism in case with dialysis using roxadustat
Serina Kita1,Hiroshi Okuyama2,Takaya Kondo1,Mizuki Hayashi1,Shinichiro Nakao1,Toshitaka Sawamura2,Keiji Fujimoto1,Atsushi Nakagawa3,Hitoshi Yokoyama1,Kengo Furuichi1
Department of Nephrology, Kanazawa Medical University1,Asanogawa General Hospital2,Department of Diabetology and endocrinology, Kanazawa Medical University3
Corresponding author Kengo Furuichi
Kanazawa Medical University Department of Nephrology
1-1 Daigaku, Uchinada, Kahoku, Ishikawa 920-0293, Japan
tel +81-76-286-2211 (ext 33401)
fax +81-76-286-2786  E-mail: furuichi@kanazawa-med.ac.jp
Keywords: hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitors, low cholesterol levels, roxadustat, central hypothyroidism
Patient consent statement: Written informed consent was obtained from the patient to publish this report in accordance with the journal’spatient consent policy.